Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 6, 2007, Pages 1317-1321

  Kang, Rhee Hun ^a,c   Wong, Ma Li ^b   Choi, Myoung Jin ^a   Paik, Jong Woo ^a,c   Lee, Min Soo ^a,c  

^a Korea University   (South Korea)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c Korea University College of Medicine   (South Korea)

Author keywords

5 HTTLPR; MDD; Mirtazapine

Indexed keywords

MIRTAZAPINE; SEROTONIN TRANSPORTER;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHARMACOGENOMICS; POLYMERASE CHAIN REACTION; PROMOTER REGION; TREATMENT RESPONSE;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHI-SQUARE DISTRIBUTION; DEPRESSIVE DISORDER, MAJOR; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIANSERIN; MIDDLE AGED; PHARMACOGENETICS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PSYCHIATRIC STATUS RATING SCALES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 34447565937     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.05.018     Document Type: Article

References (37)

1. Blier P., and de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15 (1994) 220-226
2. Bellivier F., Henry C., Szoke A., Schurhoff F., Nosten-Bertrand M., Feingold J., et al. Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression. Neurosci Lett 255 (1998) 143-146
3. de Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clin Psychopharmacol 10 (1995) 19-23
4. Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., and Heninger G.R. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychaiatry 47 (1990) 411-418
5. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Heninger G.R., Gelenberg A.J., et al. Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull 29 (1993) 389-396
6. First M.B., Spitzer R.L., Gibbon M., and Willams J.B.W. Structured clinical interview for DSM-IV axis I disorders SCID I: clinician version, administration booklet (1997), American Psychiatric Press, Washington, DC
7. Furlong R.A., Coleman T.A., Ho L., Rubinsztein J.S., Walsh C., Paykel E.S., et al. No association of a functional polymorphism in the dopamine D2 receptor promoter region with bipolar or unipolar affective disorders. Am J Med Genet 81 (1998) 385-387
8. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6 (1967) 278-296
9. Han O.S., and Hong J.P. Structured clinical interview for DSM-IV axis I disorder - Korean version (2000), Hana Medical, Seoul
10. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel S., et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 66 (1996) 2621-2624
11. Kasper S. Efficacy of antidepressants in the treatment of severe depression: the place of mirtazapine. J Clin Psychopharmacol 7 (1997) 19-28
12. Kasper S., Praschak-Riedel N., Tauscher J., and Wolf R. A risk-benefit assessment of mirtazapine in the treatment of depression. Drug Saf 17 (1997) 251-264
13. Kim J.W. Association study and the population admixture. Winter workshop on human neurobehavioral genetics in the 21st century (2003), Korean Society of Biological Psychiatry, Seoul
14. Kim D.K., Lim S.W., Lee S., Sohn S.E., Kim S., Hahn C.G., et al. Serotonin transporter gene polymorphism and antidepressant response. NeuroReport 11 (2000) 215-219
15. Kim H., Lim S.W., Kim S., Kim J.W., Chang Y.H., Carroll B.J., et al. Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA 296 (2006) 1609-1618
16. Kunugi H., Hattori M., Kato T., Tatsumi M., Sasaki T., Hirose T., et al. Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder. Mol Psychiatry 2 (1997) 457-462
17. Lee M.S., Lee H.Y., Lee H.J., and Ryu S.H. Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment. Psychiatr Genet 14 (2004) 111-115
18. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 29 (1996) 1527-1531
19. Lesch K.P. Serotonergic gene expression and depression: implications for developing novel antidepressants. J Affect Disord 62 (2001) 56-57
20. Minov C., Baghai T.C., Schule C., Zwanzger P., Schwarz M.J., Zill P., et al. Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett 303 (2001) 119-122
21. Murphy Jr. G.M., Hollander S.B., Rodrigues H.E., Kremer C., and Schatzberg A.F. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry 61 (2004) 1163-1169
22. Nelson J.C., Mazure C.M., Bowers Jr. M.B., and Jatlow P.I. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 48 (1991) 303-307
23. Ogilvie A.D., Battersby S., Bubb V.J., Fink G., Harmar A.J., Goodwim G.M., et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347 (1996) 731-733
24. Pollock B.G., Ferrell R.E., Mulsant B.H., Mazumdar S., Miller M., Sweet R.A., et al. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 23 (2000) 587-590
25. Ramamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T., Chang A.S., et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A 90 (1993) 2542-2546
26. Rausch J.L., Johnson M.E., Fei Y.J., Li J.Q., Shendarkar N., Hobby H.M., et al. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol Psychiatry 51 (2002) 723-732
27. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1 (1990) 43-46
28. Sen S., Burmeister M., and Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 15 (2004) 85-89
29. Serretti A., Zanardi R., Rossini D., Cusin C., Lilli R., and Smeraldi E. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. Mol Psychiatry 6 (2001) 586-592
30. Serretti A., Kato M., De Ronchi D., and Kinoshita T. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 12 (2007) 247-257
31. Seth R., Jennings A.L., Bindman J., Phillips J., and Bergmann K. Combination treatment with noradrenaline and serotonin reuptake inhibitors in resistant depression. Br J Psychiatry 161 (1992) 562-565
32. Smeraldi E., Zanardi R., Benedetti F., Di Bella D., Perez J., and Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3 (1998) 508-511
33. Smith W.T., Glaudin V., Panagides J., and Gilvary E. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder. Psychopharmacol Bull 26 (1990) 191-196
34. Smits K.M., Smits L.J.M., Schouten J.S.A.G., Stelma F.F., Nelemans P., and Prins M.H. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Mol Psychiatry 9 (2004) 433-441
35. Tsapakis E.M., Checkley S., Kerwin R.W., and Aitchison K.J. Association between the serotonin transporter linked polymorphic region gene and response to tricyclic antidepressants. Eur Neuropsychopharmacol 15 suppl 1 (2005) S26-S27
36. Yoshida K., Ito K., Sato K., Takahashi H., Kamata M., Higuchi H., et al. Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 383-386
37. Zanardi R., Benedetti F., Di Bella D., Catalano M., and Smeraldi E. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol 20 (2000) 105-107